KalVista Pharmaceuticals Statistics

Total Valuation

KALV has a market cap or net worth of $498.67 million. The enterprise value is $429.34 million.

Market Cap	498.67M
Enterprise Value	429.34M

Important Dates

The next estimated earnings date is Friday, July 5, 2024, before market open.

Earnings Date	Jul 5, 2024
Ex-Dividend Date	n/a

Share Statistics

KALV has 42.19 million shares outstanding. The number of shares has increased by 22.79% in one year.

Shares Outstanding	42.19M
Shares Change (YoY)	+22.79%
Shares Change (QoQ)	+0.46%
Owned by Insiders (%)	1.23%
Owned by Institutions (%)	117.74%
Float	20.70M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	5.63
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.44, with a Debt / Equity ratio of 0.07.

Current Ratio	5.44
Quick Ratio	n/a
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -86.10% and return on invested capital (ROIC) is -130.45%.

Return on Equity (ROE)	-86.10%
Return on Assets (ROA)	-72.70%
Return on Capital (ROIC)	-130.45%
Revenue Per Employee	n/a
Profits Per Employee	-$917,797
Employee Count	118
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +22.85% in the last 52 weeks. The beta is 0.90, so KALV's price volatility has been similar to the market average.

Beta (1Y)	0.90
52-Week Price Change	+22.85%
50-Day Moving Average	11.73
200-Day Moving Average	11.20
Relative Strength Index (RSI)	49.31
Average Volume (30 Days)	369,584

Short Selling Information

The latest short interest is 5.52 million, so 13.09% of the outstanding shares have been sold short.

Short Interest	5.52M
Short Previous Month	5.76M
Short % of Shares Out	13.09%
Short % of Float	26.67%
Short Ratio (days to cover)	19.64

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-123.72M
Pretax Income	-108.30M
Net Income	-108.30M
EBITDA	-107.49M
EBIT	-108.30M
Earnings Per Share (EPS)	-$3.13

Full Income Statement

Balance Sheet

The company has $75.59 million in cash and $6.26 million in debt, giving a net cash position of $69.33 million or $1.64 per share.

Cash & Cash Equivalents	75.59M
Total Debt	6.26M
Net Cash	69.33M
Net Cash Per Share	$1.64
Equity / Book Value	88.58M
Book Value Per Share	2.10
Working Capital	84.98M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$96.76 million and capital expenditures -$390,000, giving a free cash flow of -$97.15 million.

Operating Cash Flow	-96.76M
Capital Expenditures	-390,000
Free Cash Flow	-97.15M
FCF Per Share	-$2.80

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

KALV does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-22.79%
Shareholder Yield	-22.79%
Earnings Yield	-21.72%
FCF Yield	-19.48%

Analyst Forecast

The average price target for KALV is $25.00, which is 111.51% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$25.00
Price Target Difference	111.51%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on November 22, 2016. It was a reverse split with a ratio of 1:14.

Last Split Date	Nov 22, 2016
Split Type	Reverse
Split Ratio	1:14

Scores

Altman Z-Score	n/a
Piotroski F-Score	2